Washington Nationals v Philadelphia Phillies

Phillies move Ethan Martin to bullpen, Tyler Cloyd to rotation

1 Comment

Chris Branch of the News Journal reports that the Phillies have decided to move Ethan Martin to the bullpen and Tyler Cloyd to the rotation. Martin, acquired from the Dodgers last year in the Shane Victorino trade, had made seven starts since making his Major League debut against the Braves on August 2, posting a 6.90 ERA in 30 innings of work.

While Martin flashed an impressive mid-90’s fastball and a decent curve, he quickly lost steam. In his first trip through the opposing lineup, Martin held the opposition to a .618 OPS. The second time through, he allowed a .961 OPS, and his third time through, 1.488. His fastball averaged 95 MPH in the first inning but dropped below 93 MPH by the fifth inning, according to Brooks Baseball. Scouts profiled him as a future reliever and it seems like the Phillies are starting to see that, though pitching coach Rich Dubee says the team wants to “protect him”.

More from Dubee, via CSN Philly’s John Finger:

“I’m not afraid to put him in the eighth inning right now,” Dubee said. “Again, this is all trial and error. It will be interesting to see how he handles it. His stuff has played phenomenally well the first time through a lineup.

“And again, I don’t know if it’s because of fatigue, I don’t know if it’s because he burns up too much energy, but his stuff shortens up the second and third time through. I do think this guy is a gem. He will play some big role on a pitching staff. It will be a nice little change to take a different look at him.”

Cloyd was with Triple-A Lehigh Valley between June 17 and August 14, then made one start with the Phillies on the 20th, and a five-inning extra-inning relief appearance on the 24th against the Diamondbacks. He went back to Lehigh Valley on the 30th for a six-inning start and hasn’t pitched since. Martin was scheduled to start against the Padres on September 10, so that will likely be Cloyd’s next appearance.

Pirates expressing interest in Justin Masterson

Justin Masterson
AP Photo/Ben Margot
Leave a comment

Pirates pitching coach Ray Searage has become the king of the reclamation project. And it sounds like he’s about to take on another big one …

Travis Sawchik of the Pittsburgh Tribune-Review reports that the Pirates have expressed interest in free agent Justin Masterson. The expectation is that it will be a one-year deal with the goal of rebuilding the right-hander’s value in an environment where many other struggling veteran pitchers have executed significant career turnarounds.

Masterson earned his first (and only) All-Star nod in 2013 when he registered a 3.45 ERA, 195 strikeouts, and three shutouts in 32 appearances with the Indians. But he had a 5.88 ERA in 128 2/3 innings between Cleveland and St. Louis in 2014 and he continued struggling to the tune of a 5.61 ERA with the Red Sox in 2015.

It’s not clear whether the Bucs would try him as a starter or reliever.

Zack Greinke deal “could come soon,” Dodgers and Giants lead the bidding

Zack Greinke
AP Photo/Mark J. Terrill

Jordan Zimmermann signed with the Tigers on Sunday for five years, $110 million. David Price signed with the Red Sox on Tuesday for seven years, $217 million.

Two big dominos have fallen in this loaded free agent market for starting pitchers, and another big one is about to go …

FOX Sports’ Ken Rosenthal says a deal for Zack Greinke “could come soon” and it’s currently “Dodgers vs. Giants” at the top of the bidding ladder.

ESPN’s Jerry Crasnick confirms that both the Dodgers and Giants are looking for an answer from Greinke, adding that the 32-year-old right-hander seeks a five- or six-year deal with a greater average annual value (AAV) than what Price just secured from Boston. That number would be $31 million, so we’re talking something close to $32 million through 2020-2021.

Greinke opted out of the remaining three years and $71 million contract with Los Angeles in October after posting a 1.66 ERA and 0.84 WHIP across 222 2/3 regular-season innings in 2015. He finished second to the Cubs’ Jake Arrieta in the National League Cy Young Award balloting.

The Red Sox get their ace! Boston signs David Price to a 7-year, $217 million deal


Multiple reports circulated in the past week that the Red Sox would need to unload the money truck in order to sign David Price. Well, the truck just got unloaded: Pete Abraham of the Boston Globe reports that the Red Sox have signed David Price to a seven-year, $217 million contract.

This is, by far, the largest free agent contract the Red Sox have ever given a pitcher. It beats Max Scherzer‘s seven-year, $210 million deal signed last offseason as the largest ever free agent pitcher contract. Clayton Kershaw‘s contract extension with the Dodgers was for $215 million.

Price went 82-47 with a 3.18 ERA pitching in the AL East while with the Tampa Bay Rays. After being traded to the Tigers just before the 2014 trade deadline he went 13-8 with a 2.90 ERA in 32 starts. He returned to the AL East with the Blue Jays this year, going 9-1 with a 2.30 ERA in 11 starts. He also pitched in the playoffs for the Jays starting three times in four overall appearances.

The Red Sox were in dire need of pitching and they were said to be gunning for Price to fill that need. Target: acquired.

Major League Baseball’s annual drug testing report has been released

Leave a comment

MLB and the MLBPA just released the annual public report from the Joint Drug Prevention and Treatment Program’s Independent Program Administrator. It’s the annual report, mandated by the JDA, which says how many positive drug tests there were, what the drugs were, etc.

The notable numbers, which cover the period starting when the 2014 World Series ended until the 2015 World Series ended:

  • Total number of tests administered: 8,158. 6,536 of them were urine tests, 1,622 of them were blood tests for HGH;
  • 10 tests resulted in positives which led to discipline: 7 for PEDs, 2 for stimulants, one for DHEA;
  • The previous year there were 7,929 total tests with 12 which resulted in discipline;
  • There were the same number of Therapeutic Use Exemptions granted this year as last: 113. All but two were for attention deficit disorder. One was for gynecomastia, which is the swelling of the breast tissue in men due to a hormone imbalance, one was for a stress fracture in someone’s elbow.

A use exemption line item which had appeared on the list for the previous several years — hypogonadism — was not there, so congratulations to the anonymous player who was either cured or who retired.

As we always note, the number of players who got exemptions for ADD drugs is a bit higher than the occurrence of ADD in the population at large and, once you eliminate kids from ADHD occurrences, it’s likely considerably higher. But that’s none of my business.